BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2011
View Archived Issues
Suzhou Ascepion Pharmaceuticals presents new protein kinase inhibitors for cancer
Read More
Aeterna Zentaris receives grant to develop cytotoxic conjugates and related diagnostic tools
Read More
Phase IIa trial of Addex's ADX-71149 begins in schizophrenia
Read More
Hexabrix demonstrates potential for the treatment of allergic rhinitis
Read More
SST-0001 suppresses growth of MM in vivo by inhibiting heparanase
Read More
Cephalon's H3 receptor antagonist/inverse agonist CEP-26401 identified as clinical candidate
Read More
IFNG and IFNGR1 gene variants linked to atopic dermatitis with eczema heperticum
Read More
Phase II data show reduced late asthmatic response with lebrikizumab treatment
Read More
GSK patents new AMPK activators
Read More
New Toll-like receptor agonists reported by Gilead
Read More
New hepcidin antagonists for anemia reported by Vifor
Read More
New Bcl-2-like protein inhibitors designed at Novartis
Read More
Array BioPharma scientists patent novel inhibitors of mTOR
Read More
Ventrus submits SPA with revised endpoints for phase III VEN-309 study
Read More
Ariad and MolecularMD collaborate on companion T315I mutation diagnostic test
Read More
GenSpera treats first patient in phase I G-202 trial
Read More
Data Monitoring Committee recommends continuing belinostat trial
Read More
Ablynx commences phase I/II study of ALX-0061 in rheumatoid arthritis
Read More
MolMed and Fondazione Telethon agree to develop gene therapy for six rare diseases
Read More
Onyx to modify phase III FOCUS study of carfilzomib in relapsed and refractory myeloma
Read More
Ono and OncoTherapy enter license agreement for therapeutic peptide vaccines for cancer
Read More
Alnylam earns technology transfer payment from Takeda
Read More
XTL Biopharmaceuticals set to gain antipsychotic drug candidates with acquisition of MinoGuard
Read More
Cephalon set to make takeover bid for ChemGenex Pharmaceuticals
Read More
Cellceutix signs confidential disclosure agreement pertaining to autism treatment KM-391
Read More
